• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植供体选择指南:综述与建议

Heart Transplant Donor Selection Guidelines: Review and Recommendations.

作者信息

Sathianathan Shyama, Bhat Geetha

机构信息

School of Medicine, Penn State College of Medicine, 500 University Dr, Hershey, PA, 17033, USA.

Heart and Vascular Institute, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, PA, USA.

出版信息

Curr Cardiol Rep. 2022 Feb;24(2):119-130. doi: 10.1007/s11886-021-01631-y. Epub 2022 Feb 18.

DOI:10.1007/s11886-021-01631-y
PMID:35179716
Abstract

PURPOSE OF REVIEW

The rate of heart transplants, while steadily increasing, is insufficient to meet the growing list of transplant candidates. Marginal donors expand the donor pool. However, criteria used to identify donors greatly vary by institution.

RECENT FINDINGS

The International Society of Heart and Lung Transplant (ISHLT) heart transplant report of 2020 reinforced the importance of donor selection criteria on heart transplant outcomes. Existing literature challenges and reinforces the report's findings. Newer methods, such as donation after circulatory death (DCD), also recontextualize existing donor selection criteria. Transplant prediction models from international databases are poor predictors of individual centers' outcome. Further study is needed to understand associations among donor risk factors, and update the methods used for donor heart selection. In this review, we examine the current literature on extended donor criteria and recommend a model for donor selection.

摘要

综述目的

心脏移植的数量虽然在稳步增加,但仍不足以满足不断增长的移植候选者名单。边缘供体扩大了供体库。然而,各机构用于识别供体的标准差异很大。

最新发现

国际心肺移植学会(ISHLT)2020年的心脏移植报告强调了供体选择标准对心脏移植结果的重要性。现有文献对该报告的结果提出了挑战并加以强化。新的方法,如循环死亡后捐赠(DCD),也重新界定了现有的供体选择标准。来自国际数据库的移植预测模型并不能很好地预测各个中心的结果。需要进一步研究以了解供体风险因素之间的关联,并更新用于供体心脏选择的方法。在本综述中,我们研究了有关扩大供体标准的当前文献,并推荐了一种供体选择模型。

相似文献

1
Heart Transplant Donor Selection Guidelines: Review and Recommendations.心脏移植供体选择指南:综述与建议
Curr Cardiol Rep. 2022 Feb;24(2):119-130. doi: 10.1007/s11886-021-01631-y. Epub 2022 Feb 18.
2
Donation After Cardiac Death: A Necessary Expansion for Heart Transplantation.心死亡后捐献:心脏移植的必要拓展。
Semin Thorac Cardiovasc Surg. 2019;31(4):721-725. doi: 10.1053/j.semtcvs.2019.05.010. Epub 2019 May 16.
3
Heart transplantation following donation after circulatory death: Expanding the donor pool.心脏移植后捐赠:扩大供体池。
J Heart Lung Transplant. 2021 Sep;40(9):882-889. doi: 10.1016/j.healun.2021.03.011. Epub 2021 Apr 8.
4
Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.肺移植中循环死亡器官捐献:ISHLT 注册研究的 5 年随访结果。
J Heart Lung Transplant. 2019 Dec;38(12):1235-1245. doi: 10.1016/j.healun.2019.09.007.
5
The Future of heart procurement with donation after circulatory death: Current practice and opportunities for advancement.运用心死亡后捐献获取心脏的未来:当前实践和推进机会。
J Heart Lung Transplant. 2022 Oct;41(10):1385-1390. doi: 10.1016/j.healun.2022.06.016. Epub 2022 Jun 25.
6
Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death.循环死亡后进行捐献的扩大标准供体肾脏弃用的流行病学
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):317-23. doi: 10.2215/CJN.07190715. Epub 2015 Dec 14.
7
Heart Donation From Donors After Controlled Circulatory Death.控制性循环死亡供者的心脏捐献。
Transplantation. 2021 Jul 1;105(7):1482-1491. doi: 10.1097/TP.0000000000003545.
8
Influence of lung donor agonal and warm ischemic times on early mortality: Analyses from the ISHLT DCD Lung Transplant Registry.肺供体濒死期和热缺血时间对早期死亡率的影响:来自 ISHLT DCD 肺移植登记处的分析。
J Heart Lung Transplant. 2019 Jan;38(1):26-34. doi: 10.1016/j.healun.2018.08.006. Epub 2018 Aug 11.
9
Outcomes of Donation After Circulatory Death Heart Transplantation in Australia.澳大利亚心死亡后捐献供体心脏移植的结果。
J Am Coll Cardiol. 2019 Apr 2;73(12):1447-1459. doi: 10.1016/j.jacc.2018.12.067.
10
Expanding the Criteria for Heart Transplantation Donors: A Review of DCD, Increased Ischemic Times, HCV, HIV, and Extended Criteria Donors.扩大心脏移植供体标准:DCD、延长缺血时间、HCV、HIV 和扩展标准供体的回顾。
Heart Surg Forum. 2023 Oct 30;26(5):E639-E655. doi: 10.59958/hsf.6677.

引用本文的文献

1
Kinetics of Procalcitonin, CRP, IL-6, and Presepsin in Heart Transplant Patients Undergoing Induction with Thymoglobulin (rATG).接受兔抗人胸腺细胞球蛋白(rATG)诱导治疗的心脏移植患者中降钙素原、C反应蛋白、白细胞介素-6和可溶性髓系细胞触发受体-1的动力学
J Clin Med. 2025 Jul 29;14(15):5369. doi: 10.3390/jcm14155369.
2
Insights into the history and tendency of cardiac transplantation for heart failure: A bibliometric-based visual analysis.心力衰竭心脏移植的历史与趋势洞察:基于文献计量学的可视化分析
Int J Cardiol Heart Vasc. 2025 May 1;59:101691. doi: 10.1016/j.ijcha.2025.101691. eCollection 2025 Aug.
3
Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling.

本文引用的文献

1
New Approaches to Donor Selection and Preparation in Heart Transplantation.心脏移植中供体选择与准备的新方法
Curr Treat Options Cardiovasc Med. 2021;23(5):28. doi: 10.1007/s11936-021-00906-5. Epub 2021 Mar 23.
2
Effect of Hepatitis C donor status on heart transplantation outcomes in the United States.美国丙型肝炎供体状态对心脏移植结局的影响。
Clin Transplant. 2021 Apr;35(4):e14220. doi: 10.1111/ctr.14220. Epub 2021 Jan 18.
3
Cells of the adult human heart.成人心脏细胞。
通过FOXO信号通路抑制免疫炎症恶性循环的基于硅酸盐的炎症性扩张型心肌病治疗方法
Sci Adv. 2025 Apr 11;11(15):eadr7208. doi: 10.1126/sciadv.adr7208. Epub 2025 Apr 9.
4
Heart transplantation with super-aged donors older than 65 years.使用65岁以上超高龄供体进行心脏移植。
JHLT Open. 2024 Mar 15;4:100083. doi: 10.1016/j.jhlto.2024.100083. eCollection 2024 May.
5
Prediction of Donor Heart Acceptance for Transplant and Its Clinical Implications: Results From The Donor Heart Study.供心接受移植的预测及其临床意义:来自供心研究的结果。
Circ Heart Fail. 2024 Oct;17(10):e011360. doi: 10.1161/CIRCHEARTFAILURE.123.011360. Epub 2024 Sep 23.
6
Strategies for Expanding Donors Pool in Heart Transplantation.心脏移植中扩大供体库的策略
Rev Cardiovasc Med. 2022 Aug 15;23(8):285. doi: 10.31083/j.rcm2308285. eCollection 2022 Aug.
7
Cirbp suppression compromises DHODH-mediated ferroptosis defense and attenuates hypothermic cardioprotection in an aged donor transplantation model.Cirbp 抑制破坏了 DHODH 介导的铁死亡防御,减弱了老年供体移植模型中的低温心脏保护作用。
J Clin Invest. 2024 Mar 12;134(9):e175645. doi: 10.1172/JCI175645.
8
Heart transplantation: advances in expanding the donor pool and xenotransplantation.心脏移植:扩大供体库及异种移植方面的进展
Nat Rev Cardiol. 2024 Jan;21(1):25-36. doi: 10.1038/s41569-023-00902-1. Epub 2023 Jul 14.
9
The 2-year postoperative left heart function in marginal donor heart recipients assessing by speckle tracking echocardiography.斑点追踪超声心动图评估边缘供心受者术后 2 年左心功能。
Int J Cardiovasc Imaging. 2023 Aug;39(8):1449-1459. doi: 10.1007/s10554-023-02867-1. Epub 2023 May 15.
10
The Clinical Outcomes of Marginal Donor Hearts: A Single Center Experience.边缘供体心脏的临床结局:单中心经验
Korean Circ J. 2023 Apr;53(4):254-267. doi: 10.4070/kcj.2022.0197.
Nature. 2020 Dec;588(7838):466-472. doi: 10.1038/s41586-020-2797-4. Epub 2020 Sep 24.
4
Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis.供体心脏移植受者可卡因使用与长期预后:国际心肺移植学会注册分析。
J Heart Lung Transplant. 2020 Dec;39(12):1341-1350. doi: 10.1016/j.healun.2020.08.018. Epub 2020 Sep 2.
5
Statistical performance of 16 posttransplant risk scores in a contemporary cohort of heart transplant recipients.移植后 16 项风险评分在当代心脏移植受者队列中的统计性能。
Am J Transplant. 2021 Feb;21(2):645-656. doi: 10.1111/ajt.16217. Epub 2020 Sep 5.
6
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors.利用丙型肝炎病毒血症供体进行心脏移植后使用 Glecaprevir/Pibrentasvir 治疗的结果。
Clin Transplant. 2020 Sep;34(9):e13989. doi: 10.1111/ctr.13989. Epub 2020 Aug 10.
7
True, true, and possibly unrelated: Variability in donor heart acceptance practices across the United States.千真万确,但可能并无关联:美国各地供体心脏接受标准的差异。
Am J Transplant. 2020 Jun;20(6):1477-1479. doi: 10.1111/ajt.15855. Epub 2020 May 16.
8
Outcomes of Adult Heart Transplantation Using Hepatitis C-Positive Donors.使用丙型肝炎阳性供体进行成人心脏移植的结果。
J Am Heart Assoc. 2020 Jan 21;9(2):e014495. doi: 10.1161/JAHA.119.014495. Epub 2020 Jan 8.
9
Clinical outcome of donor heart with prolonged cold ischemic time: A single-center study.冷缺血时间延长的供心临床结局:一项单中心研究。
J Card Surg. 2020 Feb;35(2):397-404. doi: 10.1111/jocs.14404. Epub 2019 Dec 26.
10
Hepatitis C donor viremic cardiac transplantation: A practical approach.丙型肝炎病毒感染者供心的心脏移植:一种实用方法。
Clin Transplant. 2020 Jan;34(1):e13764. doi: 10.1111/ctr.13764. Epub 2019 Dec 30.